Literature DB >> 20065153

Aldosterone abrogates nuclear factor kappaB-mediated tumor necrosis factor alpha production in human neutrophils via the mineralocorticoid receptor.

Astrid Bergmann1, Claudia Eulenberg, Maren Wellner, Susanne Rolle, Friedrich Luft, Ralph Kettritz.   

Abstract

Mineralocorticoid receptor (MR) activation by aldosterone controls salt homeostasis and inflammation in several tissues and cell types. Whether or not a functional MR exists in polymorphonuclear neutrophils is unknown. We investigated the hypothesis that aldosterone modulates inflammatory neutrophil responses via the MR. By flow cytometry, Western blot analysis, and microscopy, we found that neutrophils possess MR. Preincubation with aldosterone (10(-11) to 10(-6) M) dose-dependently inhibited nuclear factor kappaB activation in interleukin (IL)-8- and granulocyte/macrophage colony-stimulating factor-treated neutrophils on fibronectin by IkappaBalpha Western blotting, electrophoretic mobility shift assay, and RT-PCR for IkappaBalpha mRNA. Aldosterone had no effect on tumor necrosis factor alpha- and lipopolysaccharide-mediated nuclear factor kappaB activation or on IL-8- and granulocyte/macrophage colony-stimulating factor-induced extracellular signal-regulated kinase, p38 mitogen-activated protein kinase, or phosphatidylinositol 3-kinase/Akt activation. Spironolactone prevented nuclear factor kappaB inhibition, indicating an MR-specific aldosterone effect. By RT-PCR, we found that neutrophils have 11beta-hydroxysteroid dehydrogenase. Tumor necrosis factor alpha, which is controlled by nuclear factor kappaB, increased in the cell supernatant with IL-8 treatment. Aldosterone completely prevented this effect. RT-PCR showed a strong tumor necrosis factor alpha mRNA increase with IL-8 that was blocked by aldosterone, excluding the possibility that the tumor necrosis factor alpha increase was merely a consequence of secretion. Finally, conditioned medium from IL-8-treated neutrophils increased intercellular adhesion molecule-1 expression on endothelial cells and subsequently the adhesion of IL-8-treated neutrophils to endothelial cells. These effects were reduced when conditioned medium from aldosterone-pretreated neutrophils was used, and spironolactone blocked the aldosterone effect. Our data indicate that a functional MR exists in neutrophils mediating antiinflammatory effects that are at work when neutrophils interact with endothelial cells. These data could be relevant to MR-blockade treatment protocols.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20065153     DOI: 10.1161/HYPERTENSIONAHA.109.141309

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  11 in total

1.  Essential role of ICAM-1 in aldosterone-induced atherosclerosis.

Authors:  Vincenzo Marzolla; Andrea Armani; Caterina Mammi; Mary E Moss; Vittoria Pagliarini; Laura Pontecorvo; Antonella Antelmi; Andrea Fabbri; Giuseppe Rosano; Iris Z Jaffe; Massimiliano Caprio
Journal:  Int J Cardiol       Date:  2017-01-05       Impact factor: 4.164

Review 2.  Mineralocorticoid receptors in vascular function and disease.

Authors:  Amy McCurley; Iris Z Jaffe
Journal:  Mol Cell Endocrinol       Date:  2011-06-24       Impact factor: 4.102

3.  Efficacy of selective mineralocorticoid and glucocorticoid agonists in canine septic shock.

Authors:  Caitlin W Hicks; Daniel A Sweeney; Robert L Danner; Peter Q Eichacker; Anthony F Suffredini; Jing Feng; Junfeng Sun; Ellen N Behrend; Steven B Solomon; Charles Natanson
Journal:  Crit Care Med       Date:  2012-01       Impact factor: 7.598

Review 4.  Aldosterone and inflammation.

Authors:  Kimberly C Gilbert; Nancy J Brown
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2010-06       Impact factor: 3.243

Review 5.  The emerging role of aldosterone/mineralocorticoid receptors in the pathogenesis of erectile dysfunction.

Authors:  Fei Wu; Yun Lin; Qingyong Liu
Journal:  Endocrine       Date:  2018-05-02       Impact factor: 3.633

Review 6.  An update on immune system activation in the pathogenesis of hypertension.

Authors:  Michael J Ryan
Journal:  Hypertension       Date:  2013-06-03       Impact factor: 10.190

7.  Acute effect of mineralocorticoid receptor antagonism on vascular function in healthy older adults.

Authors:  Moon-Hyon Hwang; Jeung-Ki Yoo; Meredith Luttrell; Han-Kyul Kim; Thomas H Meade; Mark English; Susanne Talcott; Iris Z Jaffe; Demetra D Christou
Journal:  Exp Gerontol       Date:  2015-11-27       Impact factor: 4.032

Review 8.  Immune Effects of Corticosteroids in Sepsis.

Authors:  Nicholas Heming; Sivanthiny Sivanandamoorthy; Paris Meng; Rania Bounab; Djillali Annane
Journal:  Front Immunol       Date:  2018-07-30       Impact factor: 7.561

9.  The aldosterone-mineralocorticoid receptor pathway exerts anti-inflammatory effects in endotoxin-induced uveitis.

Authors:  Elodie Bousquet; Min Zhao; André Ly; Guillaume Leroux Les Jardins; Brigitte Goldenberg; Marie-Christine Naud; Laurent Jonet; Bernadette Besson-Lescure; Frederic Jaisser; Nicolette Farman; Yvonne De Kozak; Francine Behar-Cohen
Journal:  PLoS One       Date:  2012-11-09       Impact factor: 3.240

10.  Spironolactone attenuates bleomycin-induced pulmonary injury partially via modulating mononuclear phagocyte phenotype switching in circulating and alveolar compartments.

Authors:  Wen-Jie Ji; Yong-Qiang Ma; Xin Zhou; Yi-Dan Zhang; Rui-Yi Lu; Zhao-Zeng Guo; Hai-Ying Sun; Dao-Chuan Hu; Guo-Hong Yang; Yu-Ming Li; Lu-Qing Wei
Journal:  PLoS One       Date:  2013-11-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.